Similarly, changes in plasma TG levels via three ANGPTL4-adjacent variants were associated with a decreased risk of CAD (OR 0.43, P = 1 × 10−21), and T2D (OR 0.62, P = 4 × 10−4) (Figure 2B). The gene discussed is ANGPTL4; the disease is coronary artery disorder.